Costs related to a Department of Justice investigation and restatement were $26.3 million this quarter, compared to $1.1 million in 2012. The company estimates the final resolution of the investigation could be $30 million.
The company’s total revenue was up slightly this quarter, from $91.7 million to $92.1 million. Second quarter product sales remained the same for both 2012 and 2013 at $87.5 million.
More Articles on Devices:
Mizuhow OSI Launches Software-Controlled Spinal Surgery Table
NDS Surgical Imaging Releases DomeAccess Software
ConforMIS Expands Series E Financing to $167M
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
